DESIGN THERAPEUTICS
Design Therapeutics is a biotechnology company developing a new class of therapies for serious degenerative disorders caused by nucleotide repeat expansions. The company’s lead program is focused on the treatment of Friedreich’s ataxia and discovery efforts are ongoing in other degenerative diseases.
DESIGN THERAPEUTICS
Social Links:
Industry:
Biotechnology Life Science Medical
Founded:
2017-01-01
Address:
Solana Beach, California, United States
Country:
United States
Website Url:
http://www.designtx.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
170.73 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network Google Universal Analytics Global Site Tag Nginx
Similar Organizations
Affinia Therapeutics
Affinia Therapeutics is a biotechnology company developing transformative AAV gene therapies for people with devastating diseases.
Atalanta Therapeutics
Atalanta Therapeutics is a biotechnology company pioneering new treatment options for neurodegenerative diseases.
Electra Therapeutics
Electra Therapeutics is a clinical stage biotechnology company developing therapies for cancer and other immunological diseases.
Seismic Therapeutic
Seismic Therapeutic is a biotechnology company advancing machine learning for immunology drug development.
Vigil Neuroscience
Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Quan Capital
Quan Capital investment in Series B - Design Therapeutics
Janus Henderson Investors
Janus Henderson Investors investment in Series B - Design Therapeutics
Wellington Management
Wellington Management investment in Series B - Design Therapeutics
BlackRock
BlackRock investment in Series B - Design Therapeutics
Logos Capital
Logos Capital investment in Series B - Design Therapeutics
Vivo Capital
Vivo Capital investment in Series B - Design Therapeutics
T. Rowe Price
T. Rowe Price investment in Series B - Design Therapeutics
RA Capital Management
RA Capital Management investment in Series B - Design Therapeutics
Surveyor Capital
Surveyor Capital investment in Series B - Design Therapeutics
WestRiver Group
WestRiver Group investment in Series B - Design Therapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2022-02-01 | Design Therapeutics Appoints Drug Development Expert, Jae Kim, M.D., as Chief Medical Officer |
Official Site Inspections
http://www.designtx.com Semrush global rank: 6.92 M Semrush visits lastest month: 695
- Host name: 83.162.211.130.bc.googleusercontent.com
- IP address: 130.211.162.83
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
